Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Clayman

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Research|November 14, 1997
Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53K K Hunt, J Deng, T J Liu, et al.
Cancer Research|June 1, 1996
DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinomaS K Kim, Y Fan, V Papadimitrakopoulou, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 1, 1990
The in vivo biologic effect of interleukin 2 and interferon alfa on natural immunity in patients with head and neck cancerS P Schantz, G Clayman, T Racz, et al.
International Journal of Cancer|April 22, 1993
Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavityG Clayman, S W Wang, G L Nicolson, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 20, 1998
Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescenceA Gillenwater, R Jacob, R Ganeshappa, et al.
Cancer Research|June 1, 1996
Genetic progression model for head and neck cancer: implications for field cancerizationJ Califano, P van der Riet, W Westra, et al.
Oncogene|April 17, 1997
Frequent inactivation of p16INK4a in oral premalignant lesionsV Papadimitrakopoulou, J Izzo, S M Lippman, et al.
Cancer|April 3, 2001
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinomaD M Shin, F R Khuri, B S Glisson, et al.
Journal of the National Cancer Institute|October 28, 1998
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapyL Mao, A K El-Naggar, V Papadimitrakopoulou, et al.
Journal of the National Cancer Institute|January 6, 2000
Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expressionD M Shin, L Mao, V M Papadimitrakopoulou, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research|November 14, 1997
Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53K K Hunt, J Deng, T J Liu, et al.
Cancer Research|June 1, 1996
DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinomaS K Kim, Y Fan, V Papadimitrakopoulou, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 1, 1990
The in vivo biologic effect of interleukin 2 and interferon alfa on natural immunity in patients with head and neck cancerS P Schantz, G Clayman, T Racz, et al.
International Journal of Cancer|April 22, 1993
Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavityG Clayman, S W Wang, G L Nicolson, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 20, 1998
Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescenceA Gillenwater, R Jacob, R Ganeshappa, et al.
Cancer Research|June 1, 1996
Genetic progression model for head and neck cancer: implications for field cancerizationJ Califano, P van der Riet, W Westra, et al.
Oncogene|April 17, 1997
Frequent inactivation of p16INK4a in oral premalignant lesionsV Papadimitrakopoulou, J Izzo, S M Lippman, et al.
Cancer|April 3, 2001
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinomaD M Shin, F R Khuri, B S Glisson, et al.
Journal of the National Cancer Institute|October 28, 1998
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapyL Mao, A K El-Naggar, V Papadimitrakopoulou, et al.
Journal of the National Cancer Institute|January 6, 2000
Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expressionD M Shin, L Mao, V M Papadimitrakopoulou, et al.
Pageof 3